Home / Rizatriptan / Canada
CA ATC N02CC04 · updated 2 Nov 2026
Rizatriptan shortage in Canada
Is there a Rizatriptan shortage in Canada?
Yes. As of 2 Nov 2026, 8 Rizatriptan products are reported short in Canada, the first since 28 Apr 2017. The company estimate for the return is 31 Dec 2026 (latest 28 Feb 2027). Main reason: manufacturing problem.
Also short in Germany, Italy, Spain, Sweden, New Zealand. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | RIVA-RIZATRIPTAN ODT (6) | LABORATOIRE RIVA INC | 28 Apr 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | AURO-RIZATRIPTAN (1x6 & 2x6) | AURO PHARMA INC | 1 Aug 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-RIZATRIPTAN IR (1 x 6) | JAMP PHARMA CORPORATION | 23 Jul 2021 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | NRA-RIZATRIPTAN ODT (6's) | NORA PHARMA INC | 1 Apr 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | NAT-RIZATRIPTAN ODT (6 UD BLS) | NATCO PHARMA (CANADA) INC | 4 Apr 2025 | 31 Dec 2026 | Other Other (Please describe in comments) |
| CA | NAT-RIZATRIPTAN ODT (6 UD BLS) | NATCO PHARMA (CANADA) INC | 4 Apr 2025 | 31 Dec 2026 | Other Other (Please describe in comments) |
| CA | MYLAN-RIZATRIPTAN ODT (6BL) | MYLAN PHARMACEUTICALS ULC | 2 Feb 2026 | 28 Feb 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MYLAN-RIZATRIPTAN ODT (6BL) | MYLAN PHARMACEUTICALS ULC | 18 Feb 2026 | 28 Feb 2027 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.